期刊文献+

成人生长激素缺乏症患者内脏脂肪指数与心血管疾病风险因素的相关性研究 被引量:6

Correlation of visceral adipose levels and cardiovascular risk factors for disease in patients with adult growth hormone deficiency
下载PDF
导出
摘要 目的探讨成人生长激素缺乏症(AGHD)患者内脏脂肪指数(VAI)水平变化及其与人体测量学指标、糖脂代谢指标和炎症介质高敏C反应蛋白(hs-CRP)、白细胞介素6(IL-6)的相关性。方法收集40例AGHD患者及40例健康人群,测量两组人群人体测量学参数及糖脂生化指标,包括体重指数(BMI)、腰臀比(WHR)、VAI、腰围身高比值(WHt R)、亮氨酸氨基肽酶(LAP)、稳态模型评价的胰岛素抵抗指数(HOMA-IR)、稳态模型评价的胰岛素分泌指数(HOMA-β)、低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)比值、总胆固醇(TC)/HDL-C比值、甘油三酯(TG)/LDL-C。结果与对照组相比,AGHD组BMI、腰围(WC)、WHR、空腹胰岛素(FINS)、HOMA-β、HOMAIR、TC、TG、LDL-C/HDL-C、TC/HDL-C、hs-CPR、IL-6、VAI均明显增高,HDL-C明显降低,差异有统计学意义(P<0.05);VAI值与WC、WHR、舒张压(SBP)、FINS、HOMA-β、HOMA-IR、TG、LDL-C/HDL-C、TC/HDL-C、TG/LDL-C、hs-CPR、IL-6呈正相关(P<0.05)。多元线性回归分析显示,hs-CRP和IL-6是VAI的独立危险因素。Pearson相关指数分析显示,VAI与脂代谢和炎症因子相关性比WC、BMI、WHR、WHt R更好。结论 AGHD患者VAI值显著高于健康人群,并与罹患心血管疾病的多种危险因素显著相关。 Objective To explore the correlation of v isceral adipose index(VAI) w ith anthropometrics, glycolipid metabolism markers, high-sensitivity C-reactive protein(hs-CRP) and interleukin-6(IL-6) in patients with adult growth hormone deficiency(AGHD). Methods A total of 40 AGHD patients from First Affiliated Hospital of Chongqing Medical University and 40 healthy adults from physical examination centre(control group), matched with age and gender, were enrolled in present study. The general anthropometrics and blood biochemical indexes were collected and compared between the two groups. Waist circumference(WC), body mass index(BMI), waist-hip ratio(WHR), waist-height ratio(WHt R), and visceral adipose index(VAI) were examined, and homeostasis model assessment-insulin resistance(HOMA-IR), homeostasis model assessment β-cell function(HOMA-β), LDL-C/HDL-C, TC/HDL-C and TG/LDL-C between the two groups were calculated. Results Compared with control group, the levels of BMI, WC, WHR, fasting insulin(FINS), HOMA-β, HOMA-IR, triglyceride(TG), LDL-C/HDL-C, TC/HDL-C, hs-CPR, IL-6 and VAI were significantly higher, but those of HDL-C were lower in AGHD group(P〈0.05). There was a positive correlation between VAI and all the factors including WC, WHR, FINS, HOMA-β, HOMA-IR, TC, LDL-C/HDL-C, TC/HDL-C, TG/LDL-C, hs-CRP and IL-6(P〈0.05). Multiple linear regression analysis revealed that hs-CRP and IL-6 were the independent risk factors of VAI. Pearson correlation index analysis showed that VAI was more correlated with lipid metabolism and inflammatory cytokines than with WC, BMI, WHR and WHt R. Conclusion VAI is significantly higher in AGHD patients than in healthy people, and it shows a strong correlation with many risk factors for cardiovascular diseases.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2016年第10期842-847,共6页 Medical Journal of Chinese People's Liberation Army
基金 重庆市科委重庆市社会民生科技创新专项资助项目(cstc2015shmszx1067)~~
关键词 成人生长激素缺乏症 内脏脂肪指数 心血管疾病 adult growth hormone deficiency visceral adipose index cardiovascular diseases
  • 相关文献

参考文献33

  • 1岑晶,顾锋.成人生长激素缺乏症诊断与治疗指南解读[J].中国实用内科杂志,2011,31(8):608-612. 被引量:10
  • 2Murray RD, Adams JE, Shalet SM, et al. Adults with partial growth hormone deficiency have an adverse body composition[J]. J Clin Endocrinol Metab, 2004, 89(4): 1586- 1591.
  • 3Abs R, Feldt-Rasmussen U, Mattsson AF, et al. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis[J]. EurJ Endocrinol, 2006, 155(1): 79-90.
  • 4Rosen T, Wiren L, Wilhelmsen L, et al. Decreased psychological wellbeing in adult patients with growth hormone deficiency[J]. Clin Endocrinol (Oxf), 1994, 40(1): 111-116.
  • 5Rosen T, Bengtsson BA. Premature mortality due tocardiovascular disease in hypopituitarism[J]. Lancet, 1990, 336(8710): 285-288.
  • 6Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group[J]. Lancet, 2001, 357(9254): 425-431.
  • 7Erfurth EM, Bulow B, Eskilsson J, et al. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results[J]. Growth Hormone IGF Res,1999, 9(Suppl A): 21-24.
  • 8夏佳佳,郑晓雅,李林蔓,刘婵,胡钰梅,陈婷颖,李晓枫,任伟.成人生长激素缺乏症患者血浆致动脉粥样硬化指数与代谢组分变化的相关性分析[J].解放军医学杂志,2014,39(12):975-980. 被引量:5
  • 9Cuneo RC, Salomon F, McGauley GA, et al. The growth hormone deficiency syndrome in adults[J].Clin Endocrinol (Oxf), 1992, 37(5): 387-397.
  • 10Weaver JU, Monson JP, Noonan K, et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults[J]. J Clin Endocrinol Metab,1995, 80(1): 153-159.

二级参考文献62

  • 1回园敕,向红丁,冯凯,李伟,许岭翎,平凡.2型糖尿病患者血超敏C反应蛋白和微血管并发症的关系[J].中国实用内科杂志,2007,27(15):1190-1192. 被引量:46
  • 2Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency : an Endocrine Society Clinical Practice Guideline[ J]. J Clin Endocrinol Metab,2006,91 (5) :1621 -1634.
  • 3Ho KK. Consensus guidelines for the diagnosis and treatment of a- dults with GH deficiency II :a statement of the GH Research Soci- ety in association with the European Society for Pediatric Endocri- nology, Lawson Wilkins Society, European Society of Endocrinolo- gy,Japan Endocrine Society, and Endocrine Society of Australia [ J ]. Eur J Endocrinol,2007,157 ( 6 ) :695 - 700.
  • 4Cook DM, Yuen KC, Biller BM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update [ J ]. Endocr Pract, 2009, 15 (Sappl 2) :1 -29.
  • 5Stochhohn K, Gravholt CH,Laursen T,et al. Mortality and GH de- ficiency : a nationwide study [ J ]. Eur J Endocrinol,2007,157 ( 1 ) : 9-18.
  • 6Yuen KC, Biller BM, Molitch ME, et al. Clinical review : Is lack of recombinant growth hormone (GH) -releasing hormone in the Unit- ed States a setback or time to consider glucagon testing tor adult GH deficiency? [ J ]. J Clin Endocrinol Metab, 2009, 94 ( 8 ) : 2702 - 2707.
  • 7Giavoli C, Libe R, Corbetta S, et al. Effect of recombinant human growth hormone(GH) replacement on the hypothalamic-pituitary- adrenal axis in adult GH-deficient patients [ J ]. J Clin Endoerinol Metab,2004,89 ( 11 ) :5397 - 5401.
  • 8Porretti S,Giavoli C,Ronchi C,et al. Recombinant human GH re- placement therapy and thyruid function in a large group of adult GH-deficient patients:when does L-T(4) therapy become manda- tory ? [ J ]. J Clin Endocrinol Metab,2002,87 (5) :2042 - 2045.
  • 9Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity [ J ]. J Clin Invest, 2004, 113 ( 1 ) : 25 - 27.
  • 10Svensson J and Bengtsson BA. Safety aspects of GH replacement [ J ]. Eur J Endocrinol,2009,161 ( Suppl 1 ) S65 - 74.

共引文献20

同被引文献54

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部